Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cells Keep to One Direction by Erasing the Path

Published: Tuesday, October 01, 2013
Last Updated: Tuesday, October 01, 2013
Bookmark and Share
Findings could have implications for cancer and metastasis.

Migrating cells, it seems, cover their tracks not for fear of being followed, but to keep moving forward. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have now shown that cells in a zebrafish embryo determine which direction they move in by effectively erasing the path behind them.

The findings, published online in Nature, could have implications not just for development but also for cancer and metastasis.

As a zebrafish embryo develops, a group of cells migrate down the side of its body, leaving clumps of cells along the way. Those clumps will become ear-like organs, sensing vibrations in the water.

In the adult fish, this is called the lateral line, so the moving mass in the embryo is dubbed the lateral line primordium. To migrate, these cells follow a trail of a molecule called a chemokine - but how do they know to keep moving in the same direction?

Scientists assumed that the trail was a one-way path: a gradient where cells moved from less- to more-concentrated chemokine. But Darren Gilmour and colleagues at EMBL have now found that, rather than being produced outside them, that gradient is actually generated by the cells themselves.

“We found that the cells at the rear of the group have a ‘vacuum cleaner’,” says Erika Donà, who carried out the work. “They suck up the chemokine at the back, but at the front there’s still a lot of chemokine to follow, so the cells move forward.”

To investigate the role of the ‘vacuum cleaner’ molecule, Gilmour and Donà turned to a ‘detector’ molecule which all cells in the primordium use to sniff out the chemokine, and which the scientists labelled with a tag that goes from green to red as the detector ages.

Cells at the front of the primordium glowed green, showing they were in such frequent contact with the chemokine that their detectors were constantly being renewed, while cells at the rear encountered so little chemokine that their detectors had a chance to grow old, painting the cells red.

To show that this gradient is created by the act of sucking up the chemokine, the scientists genetically engineered fish to have the vacuum cleaner molecule in an accompanying nerve rather than at the rear of the primordium itself. When the vacuum cleaner was switched to the nerve, the nerve went from following the migrating primordium to guiding it.

“It makes a lot of sense for the cells to choose their own direction,” says Darren Gilmour, who led the work. “There’s a lot going on in the embryo, lots of cells moving in lots of directions, so it may be very difficult to sustain a gradient. What we’ve shown is that you don’t always need to.”

The study could also be relevant to another, seemingly very different type of moving cells: those in metastasizing cancers. Scientists have found that both the ‘detector’ and the ‘vacuum cleaner’ molecule play important roles in different tumours’ ability to metastasize - to spread from one place to another in the body. These findings hint at what those roles might be, and consequently at possible ways to block them.

The color-changing tag used in this study was first developed by Anton Khmelinskii in the group of EMBL Alumnus Michael Knop, now at the DKFZ-ZMBH Alliance. Joseph Barry in the Huber group helped develop and apply data analysis methods for this work.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

DNA Protection, Inch by Inch
DNA within reproductive cells is protected through a clever system of find and destroy: new lifts the veil on how this is done.
Monday, July 13, 2015
Catching the Cap-Snatcher
Structural analysis opens the way to new anti-influenza drugs.
Tuesday, August 07, 2012
Blood-clotting Protein Linked to Cancer and Septicaemia
In our not-so-distant evolutionary past, stress often meant imminent danger, and the risk of blood loss, so part of our body’s stress response is to stock-pile blood-clotting factors.
Friday, February 04, 2011
Scientific News
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!